Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons
Asthma is a prevalent chronic non-communicable disease, affecting approximately 300 million people worldwide. It is characterized by significant airway inflammation, hyperresponsiveness, obstruction, and remodeling. Eosinophilic asthma, a subtype of asthma, involves the accumulation of eosinophils i...
Main Authors: | Musaddique Hussain, Gang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/13/5/384 |
Similar Items
-
Interleukin-13 in Asthma and Other Eosinophilic Disorders
by: Emma Doran, et al.
Published: (2017-09-01) -
The Influence of Peripheral Blood Eosinophil Counts in Asthma Comorbidities in Adults: A Real Life Study
by: Ignacio Esteban-Gorgojo, et al.
Published: (2022-04-01) -
Severe eosinophilic asthma: therapeutic potential of Reslizumab
by: R. S. Fassakhov
Published: (2018-10-01) -
Th2 cytokines and asthma — The role of interleukin-5 in allergic eosinophilic disease
by: Chapman Richard W, et al.
Published: (2001-03-01) -
Update on new biologics for intractable eosinophilic asthma: impact of reslizumab
by: Sahota J, et al.
Published: (2018-05-01)